OBJECTIVE: To identify chromosomal regions linked to plasma leptin concentrations. DESIGN: Autosomal genome-wide scan, including 516 microsatellite markers. Sib-pair (Haseman ± Elston) and variance components methods were used to assess genetic linkage. SUBJECTS: 770 Pima Indians comprising 239 nuclear families (for a total of 1199 sibling-pairs). MEASUREMENTS: Plasma leptin concentrations and body mass index (BMI), adjusted for age and sex. RESULTS: The strongest evidence for linkage with plasma leptin concentration was on chromosome 6p logarithm of odds (LOD) 2.1 by variance components analysis). There was no evidence for linkage to BMI in this region. Additional regions with marginal evidence for linkage to plasma leptin concentration (LOD ! 1.0) were detected on chromosomes 3, 11, 13, 15 and 16. CONCLUSIONS: The results suggest that a locus on chromosome 6p in¯uences plasma leptin concentrations. Replication studies are needed to exclude the possibility that linkage has been falsely detected.
Introduction
Leptin is an adipocyte-derived hormone which is thought to act on the central nervous system, in a feedback manner as part of a system to regulate energy balance. 1, 2 Circulating plasma leptin has been shown in a number of studies to be correlated with adipose tissue mass in both humans and rodents. 3 ± 6 In human populations, the correlation coef®cients between leptin and body mass index (BMI)apercentage body fat are generally in the range of 0.5 ± 0.8. 3 ± 6 Therefore, one could consider plasma leptin concentration to be a surrogate measure of obesity in a population.
However, for any given measure of body fat (e.g. BMI) there is considerable variation in plasma leptin concentrations which is not accounted for by differences in age and sex. Subjects with relatively low plasma leptin concentrations (for a given body fat content, age and sex) appear to have a pre-disposition to weight gain. 7, 8 Therefore, variability in plasma leptin concentration may have physiological relevance to the development of obesity.
We conducted a genome-wide linkage scan to identify chromosomal regions linked to plasma leptin concentration in Pima Indians, a Native American population with a high prevalence of type 2 diabetes and obesity. 9 ± 11 Previous studies of this kind in Mexican-American and French populations have identi®ed loci with evidence for linkage to plasma leptin concentrations on chromosomes 2p21, 12, 13 5cen-q 13 and 8p. 12 We also tested for linkage to BMI in this group of Pima Indians to compare with the results of the leptin linkage analysis.
Materials and methods

Subjects
The individuals are participants in ongoing longitudinal studies of type 2 diabetes in Pima Indians. 9, 14 For the present study, individuals were selected from those who had participated in a genome-wide linkage study for loci in¯uencing type 2 diabetes and related traits. 15 The full genomic scan included 1338 individuals from 332 nuclear families, comprising 112 extended pedigrees. For the present study, all nondiabetic subjects 18 y and older for whom DNA and plasma samples, and measurements of height and weight, were available were selected. After limiting this to individuals with at least one sibling, 770 individuals were selected belonging to 239 nuclear families, comprising a total of 1199 sibling pairs. Subject characteristics are detailed in Table 1 .
Phenotypes
Body mass index (BMI; kgam 2 ) was calculated from height and weight measured with subjects wearing light clothing and no shoes. For persons with multiple longitudinal examinations, the visit with the highest body weight was chosen as this most likely represents the susceptibility of the individual to obesity. Results of the full genomic scan for linkage with BMI have been reported elsewhere, 15 so BMI linkage results are only presented here in the context of comparison to linkage for plasma leptin variables at loci of interest. The BMI linkage results given here are for the same group of 770 nondiabetic individuals as for the linkage to plasma leptin, and the BMI data were collected from the same examination as that when plasma was collected for leptin measurement. These 770 individuals are a subset of the 1338 subjects in whom linkage with BMI was previously reported. 15 Plasma leptin concentrations were measured at Amgen Inc., Thousand Oaks, CA, by a solid-phase sandwich enzyme immunoassay using an af®nity-puri®ed polyvalent antibody immobilized in microtiter wells. The concentration of leptin in the samples was calculated from a standard curve generated in each assay with recombinant human leptin. This assay is sensitive to leptin concentrations of 50 pgaml; the intra-and interassay coef®cients of variation were 3 and 6%, respectively. Some older plasma samples had dehydrated and were reconstituted with appropriate volumes of water. Total cholesterol was measured in these samples and compared with original measurements at the time the plasma was drawn to ensure that the reconstitution was accurate. There was no difference in the relationship between BMI and plasma leptin concentration in the reconstituted and more recent samples.
Prior to linkage analyses, the natural logarithms of both BMI and plasma leptin were adjusted for age and sex by linear regression. (Analysis of the residuals suggested that the logarithmic transformation resulted in a substantially better ®t for these regression models.) The adjusted BMI and plasma leptin concentration were signi®cantly correlated (r 0.49, P 0.0001; Figure  1 ). In addition, a`relative plasma leptin' variable was generated by adjusting the natural logarithm of plasma leptin concentration for age, sex and BMI. In the context of the proposed leptin feedback system thought to regulate body fat mass, this variable could be thought of as a measure of leptin action.
Genotypes
The genotyping and mapping of markers in this population and veri®cation of pedigree data have been described previously. 15 Brie¯y, a total of 516 autosomal microsatellite markers were typed usinḡ uorescent or radioactive labeling of speci®c polymerase chain reaction (PCR) primers. 16, 17 The markers had a median heterozygosity of 0.68, and the median spacing between adjacent markers was 6.4 cM.
Linkage analysis
The plasma leptin variables were tested for linkage using distributions of sib-pair-marker identity by descent (IBD). Initially, Haseman ± Elston regression was used to test for linkage. 18 Sibpal 2.6 was used in the pointwise linkage to test individual markers. Approximate multipoint IBD distributions were generated from the IBD distributions of individual markers using the procedure of Fulker and colleagues 19 as previously described. 15 To account for non-independence among multiple sib-pairs within sibships, the signi®cance of the Haseman ± Elston test was assessed using a modi®ed number of degrees of freedom. 20 In addition, for both the leptin and BMI variables described above, linkage analyses were performed for sibships by means of variance-components methods, 21 as previously described. 15 Brie¯y, this method is based on ®tting a linear mixed model which provides estimates of the trait mean (m) and three components of variance: (a) an additive monogenic component linked to the region of interest; (b) a polygenic component re¯ecting overall familial effects; and (c) an environmental component incorporating effects unique to the individual. The hypothesis of no linkage to the region of interest can be evaluated by the Figure 1 Relationship between BMI and plasma leptin concentration in the Pima Indian population. The correlation coef®cient was 0.49 ( r 2 0.24); the correlation in women was 0.31, and that in men was 0.68.
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K Walder et al likelihood ratio test comparing the model in which all three variance components are estimated with one in which the monogenic component is ®xed at zero. For presentation purposes, the likelihood ratio tests were converted to equivalent LOD scores. The observed distribution of alleles shared IBD, estimated from the marker data, was used to estimate the monogenic component, while the expected distribution was used to estimate the polygenic component. In the present analysis, a Newton ± Raphson maximum likelihood procedure, implemented in the MIXED procedure of the SAS statistical package (SAS Institute, Cary, NC) was used to estimate the variance components.
Results
The relationship between plasma leptin concentration and BMI in this population of 770 Pima Indians is shown in Figure 1 . A signi®cant linear correlation was observed with a correlation coef®cient of 0.49 (P 0.0001). Plasma leptin concentration was more strongly correlated with BMI in men (r 0.68; P`0.001) than in women (r 0.31; P`0.001).
For the plasma leptin variables, LOD scores greater than 1.18 (P`0.01) using either pointwise or multipoint sib-pair (Haseman ± Elston) regression analyses are given in Table 2 . For plasma leptin concentration (adjusted for age and sex) the maximum pointwise LOD score obtained using these methods was 2.0, which corresponds to a nominal P-value of 0.0014, on chromosome 16. Using multipoint analysis, there was marginal evidence for linkage in this region (LOD 1.4). Additionally, there was some evidence for linkage with plasma leptin concentration on chromosomes 5, 6, 10 and 15 (Table 2) .
Using variance-components analysis, we obtained estimates of the additive genetic heritability of the traits analyzed. The heritability estimates were 0.21 AE 0.08 for plasma leptin concentration (adjusted for age and sex) and 0.67AE 0.11 for BMI (adjusted for age and sex). The estimate of heritability for plasma leptin adjusted for age, sex and BMI was not signi®cantly different from zero (upper limit of 95% con®dence interval 0.11).
The highest LOD score obtained in variance-components linkage analysis of plasma leptin and BMI is shown, for each of the 22 autosomal chromosomes, in Figure 2 . The only region to show suggestive evidence of linkage (LOD b 2.0) to plasma leptin concentration using this method was on chromosome 6 ( Figure  3 ). The maximum LOD score at this locus was 2.1 (corresponding to a nominal P-value of 0.001) at a map distance of 54 cM from the p-terminal, near the marker D6S271. As shown in Figure 3 , there was no evidence for linkage to BMI in this region.
In four other regions a LOD score of greater than 1 (but less than 1.18) was obtained for linkage with plasma leptin (corresponding to nominal P-values of between 0.017 and 0.011). Figure 4 a Natural log of plasma leptin adjusted for age and sex. Figure 2 Maximum LOD score obtained by multipoint variancecomponents analysis for plasma leptin and BMI (both adjusted for age and sex), by chromosome, in Pima Indians. Figure 3 Multipoint variance-components linkage results for chromosome 6 for plasma leptin and BMI (both adjusted for age and sex using linear regression). Distances are from the p-terminal of the chromosome, on the basis of a genetic map derived from a previous study using the same set of markers (15) .
depicts these
Leptin genomic scan in Pima Indians K Walder et al regions along with the evidence for linkage with BMI at these loci. In variance components linkage analyses of plasma leptin concentration adjusted for BMI, in addition to age and sex, the evidence for linkage on chromosome 6p was virtually identical to that obtained in linkage analyses of plasma leptin adjusted for age and sex alone (LOD 2.1 at 56 cM). There were no other chromosomal regions which achieved LOD b 1.0 for plasma leptin adjusted for age, sex and BMI, a ®nding which probably re¯ects the low heritability of this variable.
Discussion
In the present study we attempted to identify chromosomal regions containing genes which contribute to the quantitative variation in plasma leptin concentration and BMI in Pima Indians. The best evidence for linkage with plasma leptin was found on chromosome 6p (LOD 2.1), using the variance-components method. Using sib-pair (Haseman ± Elston) regression analyses, the best evidence for linkage with plasma leptin was on chromosome 16 (LOD 1.4). The methods used to assess linkage are potentially unduly in¯uenced by individuals with extreme phenotypic values, which could cause the evidence for linkage to be either overestimated or underestimated. However, the removal of individuals with extreme values ( b 4 s.d.) for either BMI or plasma leptin concentrations did not appreciably alter the results of the linkage analysis, nor did it alter the relationship between BMI and plasma leptin concentration (data not shown). The variance components method requires an assumption of multivariate normality and the statistical signi®cance of the linkage could be in¯ated if the distribution of the trait is radically different from a normal distribution, particularly if there is residual sibling correlation. 22 To assure that the assumption of multivariate normality was met, individuals were ranked by the plasma leptin concentration, and an inverse Gaussian transformation of the ranks was used to generate a normally distributed variable. The results of linkage analyses of this normalized variable were very similar to those presented above (data not shown), and this suggests that the present analyses are not in¯uenced by violations of the assumption of multivariate normality.
The interpretation of statistical signi®cance in genome-wide linkage studies is controversial, but LOD scores of this magnitude would generally be regarded as suggestive evidence for linkage in a genome-wide scan. 23, 24 In other words, the LOD score of 2.1 suggests that a locus on chromosome 6p in¯uences plasma leptin concentration in the Pimas, but the probability of falsely detecting linkage is not suf®ciently low for the evidence to be considered conclusive.
By variance-components analysis, the best evidence for linkage to plasma leptin concentration was on chromosome 6 (LOD 2.1, Figure 3) . The parameter estimates of the model suggested that genetic variation at this locus accounted for 22% of the variation in plasma leptin concentration, with a random environmental contribution of 78%, and the residual additive genetic component did not contribute to the variation in plasma leptin. Using the sib-pair (Haseman ± Elston) regression method, there was marginal evidence for linkage (nominal P`0.01) with plasma leptin concentration at this locus (multipoint LOD 1.2, Table 2 ). The increase in LOD score at this locus using the variance-components method is not surprising given that this method is often more powerful than sib-pair-based methods, 25, 26 as it tests the sibship as a whole unit rather than a set of independent sibling-pairs.
The locus on chromosome 6 with the best evidence of linkage to plasma leptin concentration maps to 6p12 ± 21 (http:aawww.ncbi.nlm.nih.govagenemap). Although there was no evidence for linkage with BMI at this locus in the present study, Norman and colleagues previously reported linkage of a marker in this region (TNFir24) with percentage body fat in a small sample of 88 Pima Indian families. 27 However, no linkage was detected with either percentage body fat or BMI at this locus in larger groups of Pima Indians, 15,27 ± 28 consistent with the results of this study. TNFir24 is approximately 20 cM telomeric to the location of the peak LOD score for plasma leptin in this study. In addition, a previous study in Caucasian families provided evidence for linkage between markers in this region and obesity phenotypes including skinfold thicknesses and relative weight. 29 Several studies have found evidence for association between Figure 4 Regions with LOD scores 1 for linkage with plasma leptin concentration (adjusted for age and sex) in Pima Indians using multipoint variance-components methods. Linkage to plasma leptin is indicated by the solid line, and BMI by the dotted line.
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This region on chromosome 6 also contains the HLA (human leukocyte antigen) multiple histocompatibility complex locus and has been mapped extensively. The HLA locus itself was previously shown to be associated with BMI in subjects from the Framingham Heart Study. 32 Several potential candidate genes for obesity are located in this region, including those encoding a gamma-aminobutyric acid (GABA) receptor (hGB1a), tumor necrosis factor-alpha (TNFa) and glucagon-like peptide-1 receptor (GLP1R). The precise physiological relationships between leptin and the GABA, TNFa and GLP1 systems are not clear, however all of these systems have been proposed as possible candidates in the regulation of body fat content and the pathophysiology of obesity. GABA is a central neurotransmitter, which affects food intake in rodents after intracerebroventricular administration. TNFa modulates adipocyte gene expression and differentiation, and has been implicated in the pathophysiology of obesity and insulin resistance (for a review see Ref. 33) . GLP1 is thought to be a potent central inhibitor of food intake, based on studies in rodents with GLP1 and its antagonist, exendin 9 ± 39 (for a review see Ref. 34) .
Using the sib-pair (Haseman ± Elston) regression approach, the best evidence for linkage with plasma leptin concentration was on chromosome 16 (marker D16S265, pointwise LOD 2.0, multipoint LOD 1.4, Table 2, Figure 5 ). This marker mapped very close to the BBS2 locus on chromosome 16q21. BBS2 is one of four loci linked to Bardet ± Biedl Syndrome (MIM#209900), an autosomal recessive disorder consisting of obesity, mental retardation, retinitis pigmentosa, hypogenitalism and polydactyly. A previous study also showed some evidence for linkage between another Bardet ± Biedl Syndrome locus, BBS4 on chromosome 15, and plasma leptin concentration in French families. 13 The results obtained in this study do not support those of previous linkage studies with plasma leptin. 12, 13 The relevant results (using the variancecomponents method) are shown in Figure 6 , with arrows indicating the approximate sites of linkage with plasma leptin in these other studies. Conversely, a previous study in French families found no evidence of linkage on chromosome 6 with plasma leptin concentrations (Figure 2 in Ref. 13 ), while in a Mexican-American population the maximum LOD score on chromosome 6 was approximately 0.8 ( Figure 1 in Ref. 12) . While the present analyses suggest that the loci detected in other populations are not major determinants of plasma leptin concentration in the Pimas, they do not exclude the possibility that these loci may have small, but important, effects. In this context, it is worth noting that the chromosome 2 locus has shown some evidence for linkage in Mexican-American, French, and AfricanAmerican populations. 12, 13, 35 At the chromosome 6 locus showing best evidence for linkage with plasma leptin, there was no evidence of linkage with BMI ( Figure 3) . Furthermore, adjustment of plasma leptin concentration for BMI did not diminish the evidence for linkage at this location. Our results, therefore, suggest that the genetic determinants of plasma leptin concentration and BMI are, to some extent, distinct. No chromosomal region demonstrated evidence of linkage with both BMI and plasma leptin concentration in the present study. The estimated heritability of plasma leptin concentration (0.21 AE 0.08) and its correlation with BMI (0.49) were considerably lower than that reported in other populations, 12, 36, 37 and these factors would limit the ability to detect loci with pleiotropic effects on both traits. Previous studies that have detected strong evidence for linkage with plasma leptin levels have estimated that the heritability due to the linked locus was substantially greater than 0.21. 12 Detection of loci with more modest effects will probably require a Leptin genomic scan in Pima Indians K Walder et al larger sample size than was available in the present study.
Genome-wide linkage analyses of BMI in the Pimas show strong evidence for linkage to chromosome 11q (LOD 3.6 at 141 cM). 15 In the present study, which represents a subset of approximately half of the individuals in the larger study for whom plasma leptin concentration could be measured, the strongest evidence for linkage also occurred on chromosome 11q, but the evidence for linkage was weaker than in the full genomic scan (LOD 0.9 at 144 cM; LOD 1.8 at 105 cM). This is not surprising given the smaller sample size, but it is further evidence for the limited power of the present study to detect loci with modest effects.
In summary, we have identi®ed, by linkage analysis, a region on chromosome 6p which may contain a gene or genes which in¯uence plasma leptin concentrations, but not BMI, in Pima Indians. Further studies are required to verify that this is not a false positive result, and that there exists a gene in this region which is involved in the physiology of the leptin system. Only then could the relevance of such a gene to the regulation of body fat content and the pathophysiology of obesity be assessed.
